Center News

Health services researcher joins Clinical

Trice Loggers brings expertise in comparative effectiveness, palliative care

Aug. 9, 2010
Dr. Elizabeth Trice Loggers

Dr. Elizabeth Trice Loggers, Clinical Research Division

Dr. Elizabeth Trice Loggers, a physician-researcher with a background in scientific studies, economics, policy, and sociodemographic and psychosocial determinants of health behavior, has joined the Clinical Research Division.

Trice Loggers is currently researching the comparative effectiveness of high-cost imaging for breast and lung cancer patients and working to improve supportive/palliative care for stem cell transplant patients at the Seattle Cancer Care Alliance. Her clinical expertise is in adult sarcomas. Additionally, she is teaming with Dr. Peggy Porter of the Human Biology Division on the Virtual Biospecimen Discovery project to improve infrastructure and collaboration around the use of biospecimens.

Her prior research focused on end of life care for patients with advanced cancer and disparities in this care depending on the racial/ethnic background of the patients.

Trice Loggers, who completed her medical degree and doctorate in health services research at the University of Minnesota’s School of Public Health, believes the Center and SCCA are “wonderfully supportive environments in which junior faculty can pursue academic and clinical care goals.”

“We feel very fortunate to have such a bright, young physician and investigator such as Elizabeth join our palliative care team,” said Moreen Shannon-Dudley, the SCCA’s director of Supportive Care and Specialty Clinics. “Elizabeth's expertise in end of life care and true passion for patient- and family-centered care will be extremely valuable in the development of a comprehensive Supportive Care Program for patients and families.”

Trice Loggers also leads studies at Seattle’s Group Health Research Institute.

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.